Approval For Vaccines Against COVID-19 Variants To Be Fast-Tracked - UK Regulator
Mohammad Ali (@ChaudhryMAli88) Published March 04, 2021 | 04:09 PM
COVID-19 vaccines that are modified to combat new coronavirus variants will not need to go through more time-consuming clinical studies to get approval, as long as manufacturers provide evidence that they produce an immune response, the UK regulatory agency announced on Thursday
LONDON (UrduPoint News / Sputnik - 04th March, 2021) COVID-19 vaccines that are modified to combat new coronavirus variants will not need to go through more time-consuming clinical studies to get approval, as long as manufacturers provide evidence that they produce an immune response, the UK regulatory agency announced on Thursday.
The Medicine and Healthcare products Regulatory Agency said in a statement that the new guidance was adopted by the Access Consortium, a coalition of regulatory authorities from the UK, Australia, Canada, Singapore and Switzerland.
"Alongside data on the immune response, the vaccine manufacturer would also be expected to provide evidence showing the modified vaccine is safe and is of the expected quality," the MHRA said.
In addition, data from the original robust clinical trials and the ongoing studies on real-world use of the vaccines in millions of people could be used to support any decision by the regulators.
�
Our priority is to get effective vaccines to the public in as short a time as possible, without compromising on safety. Should any modifications to authorised COVID-19 vaccines be necessary, this regulatory approach should help to do just that," MHRA Chief Scientific Officer, Dr. Christian Schneider, was quoted as saying.
The approach is based on the tried and tested regulatory process used for seasonal flu vaccines, which are modified every year to match the new strains.
The announcement comes as at least three variants "of concern" have been identified in the UK so far, including the strain first discovered in Brazil which experts fear could be more resistant to the Pfizer/BioNTech and AstraZeneca/Oxford vaccines being rolled in the UK.
Related Topics
Recent Stories
ICC Womens T20 World Cup Qualifier, Match 2: Ireland Women open with Comfortable ..
Robinson, bowlers help New Zealand go 2-1 up against Pakistan
Shahzeb Chachar to hold khuli kachehri on April 26
Heatwave amid Israel's aggression in Gaza brings new misery, disease risk
Tourism must change, mayor says as Venice launches entry fee
Court adjourns Judicial Complex attack case till May 17
Nasreen Noori’s book ‘Popatan Jahra Khwab’ launched
Wafaqi Mohtasib inspection team visits Excise and taxation office
AJLAC announces 5th Conference titled ‘People’s Mandate: Safeguarding Civil ..
Pak-US officials engage to enhance trade, investment ties
IBCC to promote educational excellence, expand regional presence
Pakistani 'Blue Helmets' serving UN Peacekeeping Mission in DR Congo set to leav ..
More Stories From World
-
Slot 'confident' of Liverpool job as 'negotiations' take place
4 hours ago -
Google parent Alphabet's Q1 profits beat estimates: company
4 hours ago -
WADA asks 'independent prosecutor' to examine Chinese swimmers case
4 hours ago -
New York court overturns Harvey Weinstein sex crime conviction
4 hours ago -
Bagnaia and Spanish rivals chase victory at Jerez
6 hours ago -
Russian, Ukrainian strikes kill at least 10 in frontline regions
6 hours ago
-
Heatwave amid Israel's aggression in Gaza brings new misery, disease risk
6 hours ago -
Tourism must change, mayor says as Venice launches entry fee
6 hours ago -
Pakistani 'Blue Helmets' serving UN Peacekeeping Mission in DR Congo set to leave after 20 years of ..
7 hours ago -
Putin says plans to visit China in May
7 hours ago -
US reinstates open internet rules rescinded under Trump
7 hours ago -
Honda announces US$11 bn EV battery and vehicle plant in Canada
7 hours ago